The FDA has granted 510(k) clearance to SmartPill to expand the use of its GI Monitoring System in the assessment of colonic transit time for patients who may have chronic constipation. The device, which includes an ingestible capsule equipped with sensors, was previously cleared for use in diagnosing gastroparesis.

Related Summaries